在甲基胺和甲基胺使用障碍的个体中表现出冲动性
Jie Yin1,2, Xinyu Cheng3, Chendi Zhou1
1School of Psychology, Beijing Sport University, Beijing, China.
Frontiers in psychiatry
|October 31, 2024
概括
患有甲基胺使用障碍 (MUD) 和甲基胺使用障碍 (MCUD) 的人表现出明显的冲动性特征,但类似的冲动行为. 这些发现凸显了物质使用障碍中冲动性的细微性质.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 成研究 研究成研究
背景情况:
- 药物使用障碍 (SUD) 与冲动控制受损有关.
- 甲基胺使用障碍 (MUD) 和甲基胺使用障碍 (MCUD) 与高冲动性有关.
- MUD和MCUD之间的冲动性的具体差异仍然不清楚.
研究的目的:
- 研究和比较MUD和MCUD患者的冲动性特征和行为.
- 通过网络分析和计算建模,探索冲动性的潜在差异.
- 在兴奋剂使用障碍中区分冲动性特征和行为.
主要方法:
- 使用巴拉特冲动性量表 (BIS),感觉寻找量表 (SSS) 和延迟折扣任务 (DDT) 评估冲动性.
- 与MUD,MCUD和健康对照 (HCs) 的个人进行了比较.
- 采用基于网络的分析和计算建模.
主要成果:
- 与MCUD受试者相比,MUD受试者在运动冲动性,非计划冲动性和总BIS得分方面的得分较高.
- 网络分析显示,MUD和MCUD组之间的中心性指数没有显著差异.
- 无论是MUD和MCUD的受试者都表现出明显高于HC的折扣率,成群体之间没有差异.
结论:
- 甲基胺使用障碍和甲基胺使用障碍的参与者在特定的冲动性特征上有所不同.
- 通过延迟折扣来衡量冲动行为,在MUD和MCUD组之间是相似的.
- 冲动性特征和行为代表了SUD中冲动性的不同维度.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
445
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
445
Attention-Deficit/Hyperactivity Disorder
45
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
45
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
163
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
163
Substance Use Disorders Affecting Sleep
160
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
160
Stimulants
160
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
160
Adrenergic Agonists: Mixed-Action Agents
669
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
669


